1. Home
  2. MREO vs NODK Comparison

MREO vs NODK Comparison

Compare MREO & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$2.02

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

NODK

NI Holdings Inc.

HOLD

Current Price

$14.55

Market Cap

296.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MREO
NODK
Founded
2015
1946
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
324.6M
296.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MREO
NODK
Price
$2.02
$14.55
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.20
N/A
AVG Volume (30 Days)
2.4M
16.7K
Earning Date
11-10-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.11
Revenue
$500,000.00
$297,973,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$131.12
N/A
P/E Ratio
N/A
$126.48
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$12.01
52 Week High
$3.88
$16.25

Technical Indicators

Market Signals
Indicator
MREO
NODK
Relative Strength Index (RSI) 50.12 59.63
Support Level $1.89 $13.92
Resistance Level $2.37 $14.70
Average True Range (ATR) 0.17 0.42
MACD -0.01 0.10
Stochastic Oscillator 40.48 74.41

Price Performance

Historical Comparison
MREO
NODK

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.

Share on Social Networks: